{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T21:45:49Z","timestamp":1788039949792,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10549-016-3964-z","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T17:57:35Z","timestamp":1472839055000},"page":"527-534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital"],"prefix":"10.1007","volume":"159","author":[{"given":"Stephanie A.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"issue":"5","key":"3964_CR1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s13058-014-0442-6","volume":"16","author":"DGR Evans","year":"2014","unstructured":"Evans DGR et al (2014) The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res 16(5):442","journal-title":"Breast Cancer Res"},{"issue":"7","key":"3964_CR2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/gim.2013.181","volume":"16","author":"DLG Borzekowski","year":"2014","unstructured":"Borzekowski DLG et al (2014) The Angelina effect: immediate reach, grasp, and impact of going public. Genet Med 16(7):516\u2013521","journal-title":"Genet Med"},{"key":"3964_CR3","first-page":"76","volume":"43","author":"K Dunlop","year":"2014","unstructured":"Dunlop K, Kirk J, Tucker K (2014) In the wake of Angelina managing a family history of breast cancer. Aust Fam Physician 43:76\u201378","journal-title":"Aust Fam Physician"},{"key":"3964_CR4","doi-asserted-by":"crossref","unstructured":"Raphael J et al (2014) The impact of Angelina Jolie\u2019s (AJ) story on genetic referral and testing at an academic cancer centre. ASCO Meeting Abstracts 32(26_suppl):44","DOI":"10.1200\/jco.2014.32.26_suppl.44"},{"issue":"6","key":"3964_CR5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jmedgenet-2015-103094","volume":"52","author":"RS Post van der","year":"2015","unstructured":"van der Post RS et al (2015) Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 52(6):361\u2013374","journal-title":"J Med Genet"},{"key":"3964_CR6","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","volume":"62","author":"HFA Vasen","year":"2013","unstructured":"Vasen HFA et al (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62:812\u2013823","journal-title":"Gut"},{"issue":"9","key":"3964_CR7","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV et al (2012) clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocr Metab 97(9):2990\u20133011","journal-title":"J Clin Endocr Metab"},{"issue":"2","key":"3964_CR8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","volume":"110","author":"S Syngal","year":"2015","unstructured":"Syngal S et al (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110(2):223\u2013262","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"3964_CR9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/M13-1684","volume":"160","author":"HD Nelson","year":"2014","unstructured":"Nelson HD et al (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. preventive services task force recommendation. Ann Intern Med 160(4):255\u2013266","journal-title":"Ann Intern Med"},{"key":"3964_CR10","unstructured":"Daly M et al (2015) NCCN guidelines version 2.2015: genetic\/familial high-risk assessment: breast and ovarian. NCCN guidelines 2015. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf . Accessed 6 Aug 2015"},{"issue":"4","key":"3964_CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","volume":"160","author":"VA Moyer","year":"2014","unstructured":"Moyer VA (2014) risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. preventive services task force recommendation statement. Ann Intern Med 160(4):271\u2013281","journal-title":"Ann Intern Med"},{"key":"3964_CR12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jamaoncol.2015.5941","volume":"6","author":"SM Rosenberg","year":"2016","unstructured":"Rosenberg SM et al (2016) BRCA1 and BRCA2 mutation testing in young women with breast cancer. JAMA Oncol 6:730\u2013736","journal-title":"JAMA Oncol"},{"key":"3964_CR13","unstructured":"Kurtzman, S et al NAPBC Standards Manual, A.C.O. Surgeons, Editor. 2014"},{"key":"3964_CR14","volume-title":"Cancer program standards 2012: ensuring patient-centered care v1.2.1","author":"FL Greene","year":"2014","unstructured":"Greene FL et al (2014) Cancer program standards 2012: ensuring patient-centered care v1.2.1. American College of Surgeons, Chicago"},{"key":"3964_CR15","unstructured":"Langreth R (2013) Cigna demands counseling for breast test in myriad threat, in Bloomberg Buisiness"},{"key":"3964_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/gim.2014.75","volume":"17","author":"D Cragun","year":"2014","unstructured":"Cragun D et al (2014) Differences in BRCA counseling and testing practices based on ordering provider type. Genet Med 17:51\u201357","journal-title":"Genet Med"},{"issue":"3","key":"3964_CR17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jmoldx.2015.01.003","volume":"17","author":"JD Riley","year":"2015","unstructured":"Riley JD et al (2015) Improving molecular genetic test utilization through order restriction, test review, and guidance. J Mol Diagn 17(3):225\u2013229","journal-title":"J Mol Diagn"},{"issue":"2","key":"3964_CR18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10689-015-9852-6","volume":"15","author":"KFL Douma","year":"2016","unstructured":"Douma KFL, Smets EMA, Allain DC (2016) Non-genetic health professionals\u2019 attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer. Fam Cancer 15(2):341\u2013350","journal-title":"Fam Cancer"},{"key":"3964_CR19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/cge.12405","volume":"87","author":"ST Vadaparampil","year":"2015","unstructured":"Vadaparampil ST et al (2015) Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of Florida. Clin Genet 87:473\u2013477","journal-title":"Clin Genet"},{"issue":"7","key":"3964_CR20","first-page":"413","volume":"74","author":"KL Brierley","year":"2010","unstructured":"Brierley KL et al (2010) Errors in delivery of cancer genetics services: implications for practice. Conn Med 74(7):413\u2013423","journal-title":"Conn Med"},{"issue":"4","key":"3964_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/PPO.0b013e3182609490","volume":"18","author":"KL Brierley","year":"2012","unstructured":"Brierley KL et al (2012) adverse events in cancer genetic testing: medical, ethical, legal, and financial implications. Cancer J 18(4):303\u2013309. doi: 10.1097\/PPO.0b013e3182609490","journal-title":"Cancer J"},{"issue":"4","key":"3964_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/PPO.0000000000000057","volume":"20","author":"DC Bonadies","year":"2014","unstructured":"Bonadies DC et al (2014) adverse events in cancer genetic testing: the third case series. Cancer J 20(4):246\u2013253. doi: 10.1097\/PPO.0000000000000057","journal-title":"Cancer J"},{"key":"3964_CR23","unstructured":"NSGC 2016 Professional status survey: executive summary (2016). www.nsgc.org . Accessed 8 Oct 2016"},{"key":"3964_CR24","unstructured":"NSGC. 2014 NSGC Professional Status Survey Executive Summary (2014) The NSGC Professional Status Survey (PSS) offers an inside view of the profession, including salary ranges, benefits, work environments, faculty status and even job satisfaction. www.nsgc.org . Accessed 28 Apr 2014"},{"issue":"4","key":"3964_CR25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1399-0004.2003.00131.x","volume":"64","author":"R Sifri","year":"2003","unstructured":"Sifri R et al (2003) Use of cancer susceptibility testing among primary care physicians. Clin Genet 64(4):355\u2013360","journal-title":"Clin Genet"},{"issue":"4","key":"3964_CR26","first-page":"295","volume":"12","author":"L Wideroff","year":"2003","unstructured":"Wideroff L et al (2003) Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomark Prev 12(4):295\u2013303","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"3964_CR27","first-page":"1070","volume":"23","author":"GW Hooker","year":"2014","unstructured":"Hooker GW et al (2014) Presented abstracts from the Thirty Third Annual Education Conference of the National Society of Genetic Counselors (New Orleans, LA, September 2014): large scale changes in cancer genetic testing with variable integration of expanded gene panels. J Genet Couns 23(6):1070\u20131071","journal-title":"J Genet Couns"},{"key":"3964_CR28","unstructured":"Bookman T (2016) Genetic counselors struggle to keep up with hugh new demand. Kaiser Health News"},{"key":"3964_CR29","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/gim.2015.179","volume":"18","author":"V Pan","year":"2016","unstructured":"Pan V et al (2016) Expanding the genetic counseling workforce: program directors\/\u2019 views on increasing the size of genetic counseling graduate programs. Genet Med 18:842\u2013849","journal-title":"Genet Med"},{"key":"3964_CR30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1200\/JCO.2013.51.3226","volume":"32","author":"MD Schwartz","year":"2014","unstructured":"Schwartz MD et al (2014) Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol 32:618\u2013626","journal-title":"J Clin Oncol"},{"issue":"2","key":"3964_CR31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10897-013-9652-9","volume":"23","author":"E McDonald","year":"2014","unstructured":"McDonald E et al (2014) Acceptability of telemedicine and other cancer genetic counseling models of service delivery in geographically remote settings. J Genet Couns 23(2):221\u2013228","journal-title":"J Genet Couns"},{"issue":"4","key":"3964_CR32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10897-013-9588-0","volume":"22","author":"SA Cohen","year":"2013","unstructured":"Cohen SA et al (2013) Identification of genetic counseling service delivery models in practice: a report from the NSGC service delivery model task force. J Genet Couns 22(4):411\u2013421","journal-title":"J Genet Couns"},{"issue":"5","key":"3964_CR33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.6004\/jnccn.2010.0046","volume":"8","author":"DJ MacDonald","year":"2010","unstructured":"MacDonald DJ, Blazer KR, Weitzel JN (2010) Extending comprehensive cancer center expertise in clinical cancer genetics and genomics to diverse communities: the power of partnership. J Natl Compr Canc Netw 8(5):615\u2013624","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"3964_CR34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1200\/JOP.2015.004838","volume":"12","author":"Y Chang","year":"2016","unstructured":"Chang Y et al (2016) ReCAP: economic evaluation alongside a clinical trial of telephone versus in-person genetic counseling for BRCA1\/2 mutations in geographically underserved areas. J Oncol Pract 12(1):59","journal-title":"J Oncol Pract"},{"key":"3964_CR35","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamaoncol.2015.3269","volume":"1","author":"S Narod","year":"2015","unstructured":"Narod S (2015) Genetic testing for BRCA mutations today and tomorrow\u2014about the about study. JAMA Oncol 1:1225\u20131226","journal-title":"JAMA Oncol"},{"issue":"8","key":"3964_CR36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.12788\/j.cmonc.0031","volume":"10","author":"S Cohen","year":"2013","unstructured":"Cohen S, McIlvried D (2013) Improving access with a collaborative approach to cancer genetic counseling services: a pilot study. Community Oncol 10(8):227\u2013234","journal-title":"Community Oncol"},{"key":"3964_CR37","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-159-10-201311190-00718","volume":"159","author":"VA Moyer","year":"2013","unstructured":"Moyer VA (2013) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: US preventive services task force recommendation statement. Ann Intern Med 159:698\u2013708","journal-title":"Ann Intern Med"},{"issue":"1","key":"3964_CR38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2009.02.017","volume":"113","author":"ACOG Committee on Practice Bulletins","year":"2009","unstructured":"ACOG Committee on Practice Bulletins (2009) Hereditary breast and ovarian cancer syndrome. Gynecol Oncol 113(1):6\u201311","journal-title":"Gynecol Oncol"},{"issue":"12","key":"3964_CR39","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2003.03.189","volume":"21","author":"American Society Of Clinical Oncology","year":"2003","unstructured":"American Society Of Clinical Oncology (2003) American society of clinical oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21(12):2397\u20132406","journal-title":"J Clin Oncol"},{"issue":"8","key":"3964_CR40","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1158\/1055-9965.EPI-13-1364","volume":"23","author":"E Mazzola","year":"2014","unstructured":"Mazzola E et al (2014) Recent BRCAPRO upgrades significantly improve calibration. Cancer Epidemiol Biomark Prev 23(8):1689\u20131695","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"11","key":"3964_CR41","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","volume":"20","author":"DA Berry","year":"2002","unstructured":"Berry DA et al (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20(11):2701\u20132712","journal-title":"J Clin Oncol"},{"issue":"11","key":"3964_CR42","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/GIM.0b013e3181b9b04a","volume":"11","author":"CA Bellcross","year":"2009","unstructured":"Bellcross CA et al (2009) Evaluation of a breast\/ovarian cancer genetics referral screening tool in a mammography population. Genet Med 11(11):783\u2013789","journal-title":"Genet Med"},{"issue":"4","key":"3964_CR43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/GIM.0b013e3181d4bc3a","volume":"12","author":"C Bellcross","year":"2010","unstructured":"Bellcross C (2010) Further development and evaluation of a breast\/ovarian cancer genetics referral screening tool. Genet Med 12(4):240","journal-title":"Genet Med"},{"issue":"1","key":"3964_CR44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3816\/CBC.2005.n.007","volume":"6","author":"JL Jones","year":"2005","unstructured":"Jones JL et al (2005) Evaluation of hereditary risk in a mammography population. Clin Breast Cancer 6(1):38\u201344","journal-title":"Clin Breast Cancer"},{"key":"3964_CR45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10689-013-9641-z","volume":"12","author":"C McDonnell","year":"2013","unstructured":"McDonnell C et al (2013) Self administered screening for hereditary cancers in conjunction with mammography and ultrasound. Fam Cancer 12:651\u2013656","journal-title":"Fam Cancer"},{"issue":"2","key":"3964_CR46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1524-4741.2009.00690.x","volume":"15","author":"EM Ozanne","year":"2009","unstructured":"Ozanne EM et al (2009) identification and management of women at high risk for hereditary breast\/ovarian cancer syndrome. Breast J 15(2):155\u2013162","journal-title":"Breast J"},{"issue":"5","key":"3964_CR47","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/ajmg.a.36453","volume":"164","author":"CE Miller","year":"2014","unstructured":"Miller CE et al (2014) Genetic counselor review of genetic test orders in a reference laboratory reduces unnecessary testing. Am J Med Genet Part A 164(5):1094\u20131101","journal-title":"Am J Med Genet Part A"},{"issue":"4","key":"3964_CR48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","volume":"160","author":"VA Moyer","year":"2014","unstructured":"Moyer VA (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. preventive services task force recommendation statement. Ann Intern Med 160(4):271\u2013281","journal-title":"Ann Intern Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3964-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3964-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3964-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T16:31:09Z","timestamp":1749573069000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3964-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,31]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3964"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3964-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,31]]}}}